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Background: Studies all over the world reported that smoking relapses occur during the first two weeks after a
quit date. The current study aimed to assess the impact of the additional phone calls counselling during the first
month on the abstinence rate at 3 and 6 months after quit date among smokers in Penang, Malaysia.
Methods: The study was conducted at Quit Smoking Clinic of two major hospitals in Penang, Malaysia. All the
eligible smokers who attended the clinics between February 1st and October 31st 2012 were invited. Participants
were randomly assigned by using urn design method either to receive the usual care that followed in the clinics
(control) or the usual care procedure plus extra counselling sessions through phone calls during the first month of
quit attempt (intervention).
Results: Participants in our cohort smoked about 14 cigarettes per day on average (mean = 13.78 ± 7.0). At
3 months, control group was less likely to quit smoking compared to intervention group (36.9% vs. 46.7%, verified
smoking status) but this did not reach statistical significance (OR = 0.669; 95% CI = 0.395-1.133, P = 0.86). However, at
6 months, 71.7% of the intervention group were successfully quit smoking (bio-chemically verified) compared to
48.6% of the control group (P < 0.001). The control group were significantly less likely to quit smoking (OR = 0.375;
95% CI = 0.217-0.645, P < 0.001).
Conclusions: Smoking cessation intervention consisting of phone calls counselling delivered during the first month
of quit attempt revealed significantly higher abstinence rates compared with a standard care approach. Therefore,
the additional counselling in the first few weeks after stop smoking is a promising treatment strategy that should
be evaluated further.
Trial registration: TCTR20140504001
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There is no specific method or technique that has been
confirmed as the best way to improve the abstinence
rates of smoking. Numerous studies have tried to find
the most effective and feasible method to assist and sup-
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unless otherwise stated.the majority (80.3%) of tobacco users tried to stop smok-
ing without assistance. Furthermore, 9% of them used
pharmacotherapy followed by counselling (4.4%) or quit-
line and others (7.6%) (Such as traditional medicines,
switching to smokeless tobacco) [1].
Several studies reported that up to 70% of the tobacco
users who quit smoking cigarettes had relapsed within
the first two weeks of their quit dates [2-4]. Thus, the
initial two weeks are considered a window period prior
to the achievement of long-term abstinence. After this
critical era, curves of relapse of the treatment and con-
trol groups in intervention studies become parallel [5-7].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 Schematic presentation of the study design.
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might enhance the probability of successful long-term
abstinence [8].
The majority of smokers prefer to cease using tobacco
products, avoiding attendance at counselling sessions or
group programmes (person-to-person contact) [9-11].
Counselling through phone calls has been paid more at-
tention as an alternative for the delivery of services
[12-15]. There are numerous potential benefits of smok-
ing cessation telephone counselling including the ease of
use, whenever required and wherever the tobacco user is
located; cost-effective delivery and scalability to a large
number of people, regardless of location; the ability to
tailor messages to key user characteristics (such as age,
sex, ethnicity); providing a content that can distract the
smoker from craving; and linking the smokers with
others for social support [16].
Therefore, in order to provide a more comfortable and
feasible intervention and to assess additional counselling
sessions during the first month after the quit date, it has
been interesting to evaluate the effectiveness of this type
of counselling using telephone calls. The results will help
to explore and assess the benefits of using loading coun-
selling sessions using telephone calls to support people
who want to quit, and to compare this method with the
usual provisions in Malaysian health care settings re-
garding the abstinence rate.
Methods
Setting and participants
The study was carried out at the Quit Smoking Clinic of
two major hospitals in Penang state, Pulau Pinang and
Seberang Jaya Hospitals. All eligible cigarettes smokers
who attended the clinics between February 1st and Octo-
ber 31st of 2012 were invited.
Inclusion and exclusion criteria
All individuals who attended the clinics during the
period under review were invited to participate in the re-
search. Inclusion criteria involved: (1) New registered
smokers who attend the Quit Smoking Clinic (either
walk-in, referred from the outpatient clinics from the
same hospital, or referred from outside primary clinics),
(2) Male or female aged ≥ 18 years old, (3) Willing to
stop smoking. In addition, all outpatient clinics of both
hospitals were contacted to refer any smoker patient
willing to stop smoking to Quit Smoking Clinic.
While the exclusion criteria consisted of: (1) Any in-
patient referred to the Quit Smoking Clinics, (2) Recent
(three months or below) history of serious cardiac
arrhythmia, angina pectoris, myocardial infarction, or
other medical conditions that from researchers' view
participants might not be commitment with the study,
(3) Currently using NRT or other smoking cessationtreatments (bupropion or varenicline) within the last
12 months before study enrolment, (4) Use tobacco prod-
ucts other than cigarettes, (5) Pregnant, lactation or intend
to be pregnant, (6) Use of Psychoactive drugs, (7) Sus-
pected drug or alcohol abuse, (8) Patients who continue to
buy nicotine gum after the first 2 weeks of treatment (as a
normal policy in these hospitals, the patients are supplied
free nicotine gum for 2 weeks only after that if the patients
wants to continue use NRT must buy it themselves).Study design
Participants were randomly assigned using urn design to
receive either the usual care (a combination of nicotine
gum and cognitive behaviour therapy); (control group),
or the previous combination plus extra counselling ses-
sions through phone calls during the first month of the
quit attempt (intervention group) (Figure 1). The pur-
pose and required adherence to the study protocol were
explained to the participants, and signed consent was
obtained from each participant by expert counsellors.
The expert counsellors at quit smoking clinic of both
hospitals who were specialists in delivering smoking ces-
sation services and who were in charged to provide
counselling support as a part of the national health ser-
vices accepted to cooperate in the present study.
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A minimum sample size of 123 subjects per group was
powered to detect a difference of at least 11% between the
intervention group and control group. Allowing for 20%
dropout, the final sample size was 148 subjects per arm.
This was based on data from a study by Ron Borland
et al., which compared the effectiveness of a telephone
call-back counselling intervention with the provision of
self-help resources alone for quitting smoking [17]. The
total target sample size was 296 subjects.
Randomisation
The selection of the method to randomise the patients
to treatment groups is one of the important statistical is-
sues in comparative trials. Although the target sample
size of the current trial was determined beforehand, the
actual number of participants recruited into the trial
may not be known in advance. Urn design was used for
randomisation because it have the ability to impose a
small trial to be balanced but acts like complete ran-
domisation as the size of the trial increases. Conse-
quently, the assignments of treatment within a sequence
created by the urn design are not as predictable as those
of other types of restricted randomisation processes, and
the susceptibility to bias is likewise reduced [18].
Procedure
After the assessment for the eligibility, the participants
were randomised and allocated to the specific groups.
All participants during the baseline visit were interviewed
by the expert counsellor. The counsellor interviewed them
using intense counselling approach for about 20–30 mi-
nutes. The study participants were asked about their
socio-demographic (age, sex, race, marital status, educa-
tion level), medical background, and smoking-related
information history (age started to smoke, number of ciga-
rettes smoked per day, previous quit attempt), the level of
nicotine dependence using the Malay version of Fager-
strom Test for Nicotine Dependence (FTND-M) [19] and
their confidence in quitting by self-reported efficacy (i.e.
how they rate their chance of stopping smoking perman-
ently at the current attempt) using a 5-point Likert scale
(very high, high, neutral, low and very low), and exhaled
carbon-monoxide (CO) level (higher intensity counselling
refers to an intervention that involves extended contact
between the patient and the clinician of more than 10 mi-
nutes [20,21]). The exhaled CO level was measured by
using the Smokerlyzer MicroCO® meter (Micro Medical
Limited Company). The concentration of CO from the
breath was measured, with a cut-off point CO level of ≥ 7
part per million (ppm) as indicative of smoking.
The smokers learnt about the negative effects of smok-
ing and their effect on health as well as the positive effect
from stopping it. In addition, all participants received freenicotine gum supplements for 2 weeks only according
to general regulations and policies followed in the Min-
istry of Health Malaysia. They learnt how to use NRT,
gained knowledge about smoking withdrawal symptoms
and how to control themselves against any of these
withdrawal symptoms or cravings for cigarette smoking,
especially during the first two weeks after quitting.
Moreover, each smoker received self-help materials in
the form of brochures and booklets on stopping smok-
ing in Malay and Chinese languages to help him/her re-
view what he/she has learnt from the counsellor. These
materials have been developed and published by the
Health Education Division, Ministry of Health Malaysia,
and reported the harmful effects and health conse-
quences of smoking. In addition, one of the booklets
displays the objectives of the Quit Smoking Clinic, in-
cluding clinic processes to achieve its goals and other
activities.
The participants, who randomised to the control group,
received the usual care which is recommended by the
Ministry of Health, Malaysia. According to Malaysian clin-
ical practice guidelines for the treatment of tobacco use
and dependence the counsellor conduct individual coun-
selling for the smoker who wants to quit by providing him
all the support and advices as well as self-help materials
[22] (see Figure 1). During the counselling session, which
last for 20–30 minutes, the counsellor emphasised and
reviewed problem solving and training procedures for
each participants to support quitting [22].
For those in the usual care group, during the first
month of the study, the participants attended the Quit
Smoking Clinic four times with a gap of one week be-
tween each visit. In the second month, the participants
were asked to attend the clinic once every two weeks
(totally 2 visits per month) and received an extra phone
call one week after each visit (totally 2 phone calls per
month). Furthermore, during the third month, partici-
pants received two phone calls and were asked to attend
the clinic at the end of the month.
In the intervention group, the smokers received the
same care procedure, except that they received an extra
proactive phone call each week besides attending the
clinic only in the first month (i.e., four visits + extra four
phone calls). The procedure for the other two months
was the same as for the control group.
During the extra phone call counselling sessions, the
counsellor encouraged smokers to endure with their at-
tempt to quit and concentrated on their success so far. He
provided them information about the harmful effects of
smoking and provided them positive feedback and empha-
sised the benefits of stop smoking. He encouraged the par-
ticipants to cease the usage of cigarettes, lighters, and
ashtrays, and to avoid any environment where they would
usually smoke. Furthermore, the counsellor prompted the
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stop smoking and strategy how to overcome them. The
counsellor talked for about 10–15 minutes with every par-
ticipant in each proactive extra phone call.
The main objective for the study was determining the
self-reported point-prevalence abstinence (the previous
4 weeks) verified by exhaled CO level at 3 and 6 months
follow-up points. At the end of the third month, the to-
bacco users were asked about their smoking status and
were asked to attend the Quit Smoking Clinic again after
3 months (6 months from the baseline visit) to assess
smoking status (4 weeks-point prevalence abstinence).
Participants who chose not to attend the visit at the end
of the third month or the visit at the end of the sixth
month were considered smokers at that point (at the end
of three month, 7 participants in control group and 3 par-
ticipants in intervention were lost to follow-up. While at
the 6-month follow-up point, 13 in the control group and
5 in the intervention group were lost). The outcomes data
was collected by another research member not connected
with counselling and the data analysis.Statistical analysis
The collected data was analysed using SPSS version 18.0
(SPSS Inc., Chicago, IL). The level of significance was set
at P value less than 0.05. Descriptive statistics were used
to display the baseline characteristics for the whole sam-
ple population, including the socio-demographic and
smoking-related information. The continuous variables
were shown as mean ± standard deviation, while the fre-
quencies and proportions were used in order to describe
the categorical variables. The comparability of demo-
graphic and smoking-related information between the
control group and the intervention group was assessed
using independent-sample t-test or Mann–Whitney U
test were used for continuous variables, and Pearson’s
chi-square (χ2) and Fisher’s exact test for categorical
variables.
Smoking cessation outcomes were compared between
the intervention group and the control group using
Mann–Whitney U test and Fisher’s exact test at third
and sixth months. These nonparametric statistical tests
were also performed to compare smoking abstinence
rates (4 weeks point prevalence abstinence) between the
two groups at 3- and 6-month follow-up points. In
addition, binary logistic regression was employed to pre-
dict the impact of the extra phone calls (the integrated
intervention) on the smoking cessation outcomes. The
effectiveness of additional counselling in the first month
of the quit attempt compared with the usual care on the
prevalence of smoking abstinence was assessed through
odds ratio (OR), and binary logistic regression was used
to control the effect of the confounder.Ethical approval
The present study was approved by the Institute of Public
Health (IPH), the National Institutes of Health (NIH) and
the Medical Research and Ethics Committee (MREC) of
the Ministry of Health, Malaysia.Results
The baseline characteristics of the study participants
Corresponding to 283 subjects identified between February
1st and October 31st 2012, 231 smokers accepted to par-
ticipate in the study. Unfortunately, recruitment procedure
was prematurely stopped because of time and financial re-
striction as well as the involvement of the Clinics in a large
project organised by the Ministry of Health, Malaysia.
Of 231 participants, 111 (48.1%) smokers were ran-
domly assigned to the usual care group, while the rest
(120 smokers) of them allocated to the intervention
group. The mean age with standard deviation (SD) of
the participants at the time of enrolment into the study
was 48.26 ± 13.7 years (range 18 – 77 years) (Table 1).
The majority of our cohort was Chinese (114/231). The
vast majority of the study participants were male (96.1%)
and 67.5% were married. In addition, 67.5% of our sub-
jects were referred from the outpatient clinics of the
same hospital. Furthermore, majority of the study partic-
ipants had a low level of education (more than 90% fin-
ished either primary or secondary school only).
Two hundred and twenty one (95.7%) of the study par-
ticipants had a history of chronic diseases such as hyper-
tension, diabetes mellitus, asthma, and heart disease.
The highest frequency among these comorbidities was
hypertension (98 patients) then diabetes mellitus and
dyslipidaemia (66 patients for each).
The mean age of starting smoking in the study popula-
tion was 17.38 ± 3.9 years (range 8 – 35 years). The
tobacco users smoked about 14 cigarettes per day on aver-
age (mean = 13.78 ± 7.0; range 3 – 50 cigarettes per day).
In addition, the mean FTND-M score was 3.79 ± 1.2
which considers low addiction according to the score
range of FTND-M. The majority of the study participants
did not try to quit smoking in the past (87.9%).
Moreover, there were no significant differences be-
tween the control and intervention groups with regards
to baseline socio-demographics and smoking history
data (Table 2). However, group type (control versus
intervention group) was significantly associated with the
participants’ category (P = 0.025), i.e. walk-in, referred
from the outpatient clinics from the same hospital, or
referred from outside primary clinics, as the majority
of the subjects in both group were referred from out-
patient clinics of the same hospital. Thus, this baseline
difference between groups was controlled in subsequent
analyses.
Table 1 Demographic and smoking-related characteristics




Referred from outside-hospital clinic 70 (30.3%)
Referred from outpatient clinic 156 (67.5%)
Walk-in 5 (2.2%)
Age (mean ± SD) (years) 48.26 ± 13.7
















No formal education 1 (0.6%)
Smoking habits/history
Age started smoking (mean ± SD) 17.38 ± 3.9
Duration of smoking (mean ± SD) 31.03 ± 13.7
No. of Cigarettes smoked/day (mean ± SD) 13.78 ± 7.0
Breath Co level (ppm) (mean ± SD) 14.45 ± 4.9




Other smokers in household
No 150 (64.9%)
Yes 81 (35.1%)
Note. SD = Standard Deviation; CO = carbon monoxide; ppm = part per million;
FTND = Fagerström test for nicotine dependence.
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Participants were monitored during the follow-up visits in
the third and sixth months for smoking status (4-week
point prevalence abstinence), exhaled CO level as a
marker to verify quitting, and number of cigarettes
smoked per day in case the participant was still smoking.
The smoking cessation outcomes were compared be-
tween the study groups and are presented in Table 3. Atthe three months follow-up visit after the quitting date,
participants who received the additional counselling in
the first moth had significantly higher rate of success in
quitting smoking when compared with those who re-
ceived the usual care alone depending on self-reporting
the 4-week point prevalence abstinence (57.5% vs. 44.1%,
respectively: P = 0.049). However, the smoking status for
the participants after verification of exhaled CO level did
not significantly differ between the study groups.
In addition, 6 months after the quit date, the self-
reported 4-week point prevalence was significantly higher
in the intervention group compared with those in the con-
trol group (74.2% vs. 51.4%, respectively: P < 0.001). Simi-
larly, the verified smoking status was significantly different
between the usual care and combination of usual care and
extra phone calls (48.6% vs. 71.7%, respectively: < 0.001).
Risk estimation of integrated intervention on the smoking
cessation outcomes
At the three month follow-up point, the participants in
the usual care group were less likely to quit smoking,
but this did not reach statistical significance (OR = 0.669;
95% CI = 0.395-1.133, P = 0.86) (Table 4). In addition,
the intervention cohort group was 1.209 times more
likely to quit smoking when compared to the control
group (95% CI = 0.945-1.545). Similarly, at six months,
the control group was 0.375 times less likely to quit
smoking (95% CI = 0.217-0.645, P < 0.001).
After controlling for the effect of confounder (partici-
pants’ category) by using binary logistic regression, the
usual care group was less likely to report non-smoking
at the 3 and 6 months follow-up points. Although, at
3 months the result failed to reach statistical significance
(adjusted OR = 0.732, P = 0.255).
Discussion
Demographic characteristics of the study participants
The tobacco users of the current study were predomin-
antly male (96.1%). This probably reflects the previously
reported statistics of the NHMS III. Cigarette smoking is
tremendously rare among Malaysian females [23]. Fur-
thermore, the report of the Global Adult Tobacco Survey
(GATS) in Malaysia reported that 22.9% of individuals
aged 15 years or older (43.6% of males and 1% of females)
were current smokers of cigarettes including manufac-
tured, hand-rolled, or kreteks [1]. Numerous studies re-
ported that while cigarettes smoking remains acceptable
for males, smoking by women is not socially sanctioned in
Malaysia and other Asian countries in general [24-26].
This suggests that quitting for female smokers is unlikely
because they did not reveal the truth about their smoking
status; hence the study was dominated by men.
The majority of the study participants had a history
chronic disease (such as hypertension and diabetes mellitus).
Table 2 Demographic and smoking-related characteristics
of control versus intervention groups
Characteristics Group type P valuea
Control Intervention




40 (36.0%) 30 (25.0%)
Referred from outpatient clinic 71 (64.0%) 85 (70.8%)
Walk-in 0 (0%) 5 (4.2%)
Age (mean ± SD) (years) 48.30 ± 13.6 48.22 ± 13.8 0.964b
Weight (mean ± SD) (kg) 62.77 ± 6.6 61.46 ± 9.8 0.499c
Sex 0.502d
Female 3 (2.7%) 6 (5.0%)
Male 108 (97.3%) 114 (95.0%)
Race 0.063
Malay 49 (44.1%) 39 (32.5%)
Chinese 53 (47.7%) 61 (50.8%)
Indian 9 (8.1%) 20 (16.7%)
Marital Status 0.086
Single 22 (19.8%) 20 (16.7%)
Divorced/Widow 10 (9.0%) 23 (19.2%)
Married 79 (71.2%) 77 (64.2%)
Education status 0.718
Primary 54 (48.6%) 55 (45.8%)
Secondary 46 (41.4%) 54 (45.0%)
Collage/University 11 (9.9%) 10 (8.3%)
No formal education 0 (0%) 1 (0.8%)
Chronic Disease 0.519
No 6 (5.4%) 4 (3.3%)
Yes 105 (94.6%) 116 (96.7%)
Smoking habits/history
No. of Cigarettes smoked/day 14.54 ± 7.6 13.08 ± 6.3 0.111c
Age started smoking 17.52 ± 4.07 17.24 ± 3.8 0.931c
Duration of smoking 31.09 ± 13.5 30.97 ± 13.9 0.946b
Breath Co level 14.93 ± 5.2 14.00 ± 4.4 0.300c
FTND-M score 3.88 ± 1.2 3.71 ± .1 0.323c
Other smokers in household 0.214d
No 77 (69.4%) 73 (60.8%)
Yes 34 (30.6%) 47 (39.2%)
Previous smoking attempt 0.105d
No 102 (91.9%) 101 (84.2%)
Yes 9 (8.1%) 19 (15.8%)
Chance rate to quit 0.916
Very high 0 (0%) 0 (0%)
High 28 (25.2%) 33 (27.5%)
Table 2 Demographic and smoking-related characteristics
of control versus intervention groups (Continued)
Neutral 67 (60.4%) 71 (59.2%)
Low 16 (14.4%) 16 (13.3%)
Very low 0 (0%) 0 (0%)
aChi-square (χ2) test, bIndependent sample t-test, cMann–Whitney U test,
dFisher’s exact test.
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tobacco users intended to stop smoking when they en-
countered medical health problems. In 2011, GATS
Malaysia reported that about one-third of the popula-
tion of current smokers and former smokers who had
been abstinent for less than one year had visited a health
care provider. Out of them, 68% had been asked by their
health care providers if they smoked and about 53% had
been recommended to stop smoking by their clinicians
[1]. Therefore, more attention and extra effort should
be focused on increasing the health awareness program
about smoking and risk-associated with smoking even
for healthy individual.
The majority of our participants were referred by either
outpatient clinics or outside clinics. Surprisingly, no tuber-
culosis patients were referred to the Quit Smoking Clinics
during the data collection of the current study. Although,Table 3 Smoking cessation outcomes of the control
versus intervention conditions
Outcomes Group type P valuea
Control Intervention





Yes 49 (44.1%) 69 (57.5%)
No 62 (55.9%) 51 (42.5%)
Breath CO level 7.75 ± 3.9 7.24 ± 3.6 0.334b
Smoking status (verified) 0.144
Non smoker 41 (36.9%) 56 (46.7%)





Yes 57 (51.4%) 89 (74.2%)
No 54 (48.6%) 31 (25.8%)
Breath CO level 7.12 ± 4.3 5.73 ± 3.5 0.005b
Smoking status (verified) < 0.001
Non smoker 54 (48.6%) 86 (71.7%)
Smoker 57 (51.4%) 34 (28.3%)
aFisher’s exact test; bMann–Whitney U test.
Table 4 Risk estimation of quit smoking with regards to group type at 3 and 6 months follow-up points
Outcomes Group type OR 95% CI P value
Control Intervention
N = 111 N = 120
At 3 months
Smoking status 0.669a 0.395-1.133 0.86
Non smoker 41 (36.9%) 56 (46.7%)
Smoker 70 (63.1%) 64 (53.3%)
Smoking status 0.732b 0.420-1.512 0.26
Non smoker 41 (36.9%) 56 (46.7%)
Smoker 70 (63.1%) 64 (53.3%)
At 6 months
Smoking status 0.375a 0.217-0.645 < 0.001
Non smoker 54 (48.6%) 86 (71.7%)
Smoker 57 (51.4%) 34 (28.3%)
Smoking status 0.376b 0.224-0.671 0.001
Non smoker 54 (48.6%) 86 (71.7%)
Smoker 57 (51.4%) 34 (28.3%)
Note. OR = odds ratio; CI = confidence interval.
aCrude odds ratio, bAdjusted odds ratio for participants category.
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berculosis patients was high and ranged from 40.3% to
53.4% in the state of Penang, Malaysia [27,28]. Furthermore,
smoking is an independent predictor of poor tuberculosis
treatment outcomes and prognosis [28] and that integrating
tobacco cessation intervention in tuberculosis care confer
advantages on the outcomes of tuberculosis treatment [29].
Therefore, more attention should be given to this group of
patient.
Effect of the integrated intervention on smoking
cessation outcomes
Finding from the current study demonstrated that self-
reported point prevalence abstinence in the intervention
arm was significantly higher than those in the control arm
at 3 and 6 months. However, a biochemically-verified ab-
stinence rate among the participants experiencing loading
counselling through phone calls was higher in the subjects
of the intervention group (74.2% versus 51.4%) and this
was statistically significance at the end of 6 months only
after the quit date (P < 0.001). Despite the believed object-
ivity of the CO biochemical measure, it does not provide a
gold standard nor is it a perfect of accuracy in assessing
smoking status [30]. Since smoking by-products have
short half-life in the body, the biochemical assessment of
smoking status using Smokerlyzer is verified for the
time only near the specimen collection (i.e., 24–48
hours) [31]. However, some participants didn’t pass the
biochemical assessment at the end of 3 and 6 monthsand therefore were considered smoker. This suggests
that smoking validation using CO as a chemical bio-
marker resulted in the evaluation and the conformation
of the self-report accuracy.
In addition, the subjects in the intervention group
were more likely to be abstinent (using verified 4-week
point prevalence abstinence) at the end of three and six
months. However, it was statistically significant at the
end 6 months (OR = 1.644, 95% CI = 1.222 - 2.212). Our
finding suggesting that more intensive counselling dur-
ing the critical period of quitting attempt (i.e. during the
first month) could have a beneficial impact on long
term. Similarly, a study was conducted in the United
States, where people living with HIV/AIDS were rando-
mised either to usual smoking cessation treatment or to
a cell phone intervention. In the intervention group, the
phone calls spanned a period of 3 months but were front
loaded such that the majority of the phone calls were
near the time of the scheduled quit date. At the end of
third months, the patients in the intervention group
were 4.3 (95% CI = 1.9 - 9.8) times more likely to quit
smoking (7-day point prevalence abstinence) compared
with the usual care participants [32]. Another study that
compared the efficacy of front loaded versus weekly be-
havioural smoking cessation used a counselling schedule
to increase the likelihood of successful early abstinence
and subsequent long-term abstinence among 278 adult
tobacco users [33]. At the end of 12 months post-
quitting, intervention participants were more likely to be
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weekly counselling schedule with regard to continuous
abstinence, 7 or more consecutive days nor for 7 or
more consecutive episodes, and point prevalence abstin-
ence. However, it was significant only when continuous
abstinence was used (11.7% vs. 6.3%, P = 0.007) [33].
Another study reported that the strength of motivation
to quit smoking, but not dependence, predicted success
at abstinence [34]. This raises the possibility that in
countries such as Malaysia that are at an earlier stage in
the “tobacco epidemic” [35] motivation plays a vital role
in success at quitting than dependence. This could hap-
pen if there are still large numbers of tobacco users who
find it relatively easy to quit.
A potential limitation of the current study is the rela-
tively small sample size (the supposed target sample
size 296 subjects, while the collected sample size was
231 subjects). However, by using the urn design ran-
domisation, this problem was resolved to ensure ran-
domisation between groups. Another limitation is that
96% of the recruited participants were males. There-
fore, the generalizability of our results to their counter-
part females might be compromised. Applying a single
biomarker for the verification of the smoking status
might result in misclassification and using an analytical
method involved two or more biomarker (cotinine in
plasma, saliva, or urine; thiocyanate in plasma or saliva;
and CO in expired air) to distinguish objectively be-
tween smokers and non-smokers is recommended [36].
However, collection of sample involves more contact with
participants than usual in field studies may result in in-
creased refusal [37]. Due to this and financial restriction,
only exhaled CO level was used for the biochemical assess-
ment. Moreover, researches demonstrated that spouses
impact each other behaviours. Since the smoking rate in
Malaysian women is low and the majority of our cohort
was male, this may affect the decision to quit smoking of
their male spouse. Other external factors may influence
the subject’s decision to quit smoking such as the increas-
ing cost of living, price of goods including cigarettes, and
others. These factors might contribute to the difference
observed in the abstinent rate between the 3rd and 6th
month follow up period, however we cannot fully under-
stand the effect of these factors from the current data.
Conclusion
In summary, Smoking cessation intervention consisting of
extra sessions of phone call counselling during the first
month of a quit attempt results in significantly higher ab-
stinence rates compared with a standard care approach.
While the results from the current study are encouraging,
12-month outcome analyses will be needed to better
evaluate the effectiveness of this kind of loading approach
at long term. Therefore, this study provides evidence thatadditional counselling during the first few weeks after the
quit date is a promising treatment strategy that should be
evaluated further.
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